Featured Attorney
Matthew J. Malinowski
Partner
Mr. Malinowski focuses his practice on highly complex "bet the company" litigation. He has truly worked his way through the ranks of the Firm, starting as a front-line litigation paralegal after graduating from college in 1998. Today, as a Firm partner, he specializes in the areas of medical device and pharmaceutical products liability defense, high-stakes lost business value and business interruption claims, and putative class action and mass groundwater and soil contamination cases. Read more >
Verdicts & Opinions
-
Meng v. Novartis Pharm. Corp., No. MID-L-7670-07-MT (N.J. Super. Ct. Law Div. May 15, 2013)
New Jersey jury finds no failure to warn in Zometa® suit.
-
Wheeler v. Novartis Pharm. Corp., Case No. 1:11-cv-00211 (S.D. Ga. May 15, 2013)
Southern District of Georgia grants Novartis summary judgment in federal Zometa® case.
-
Oregon court becomes latest federal court to dismiss punitive damages claim In Aredia®/Zometa® litigation.
-
Novartis prevails on summary judgment as Texas Statutory Presumption of Adequacy blocks plaintiffs’ claims.
-
Guenther v. Novartis Pharm. Corp., No. 6:08-cv-00456-GAP-DAB (M.D. Fla. Mar. 26, 2013)
Novartis wins motion to apply New Jersey punitive damages law in M.D. Fla.
News & Publications
-
-
Law360: Novartis Wins Jury Verdict Over Zometa's Bone Death Risk
"After fewer than six hours of deliberations . . . the jury in Middlesex County Superior Court handed down its 7-1 decision in the case of Beverly Meng shortly after 11 a.m. Meng's lawsuit was the second to go on trial in the New Jersey mass tort, and Novartis has won both."
-
Six Firm Partners Named to the 2013 Washington, DC Edition of Super Lawyers.
-
Hollingsworth LLP hosts its 25th Annual Seminar at the U.S. Chamber of Commerce.
In 2013, the Firm celebrated the 25th anniversary of its Annual Seminar on Complex Litigation Defense—the longest-running continuous event of its kind in the country.
-
The DynCorp ruling is a welcome and much needed rebuke to international activist efforts to demonize U.S. industry through unfounded legal actions arising from international operations.
-
Law360: Fla. Judge Nixes Punitive Damages In Novartis Zometa Row
"A Florida federal judge on Wednesday nixed punitive damages from a lawsuit alleging Novartis Pharmaceuticals Corp.'s Aredia and Zometa bone drugs caused a woman to develop osteonecrosis of the jaw, finding that New Jersey law limiting punitive damages in such cases applies."
-
The Legal Times quotes partner Eric Lasker on DynCorp win in mass tort Plan Colombia litigation.
-
AmLaw Litigation Daily Names Partners Eric Lasker and Rosemary Stewart "Litigators of the Week."
AmLaw Journal highlights DynCorp success as counter to Chevron's legal troubles in Ecuador.
-
The Chamber Is Right: A Response to the Legal Funding Industry.
By Kirby T. Griffis
-
Briefright blog post - The Gettysburg Address in Legalese
Legalese is the characteristic style of legal documents; it is full of many bad writing techniques. This post demonstrates how the Gettysburg Address is transformed into an ugly and incomprehensible mess by rendering it in legalese.
-
To view the agenda or for more information on this event, please click above.








